GlassScriptPhysician profile
Philipp Leucht
NPI 1740414119
$260,147.93
in general payments reported to CMS, 2019-2025
8 companies · $28K in 2025
The $28K reported for 2025 was more than what 88% of Orthopaedic Trauma providers received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39K · 2020: $11K · 2021: $52K · 2022: $54K · 2023: $54K · 2024: $21K · 2025: $28K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $89K · Travel and Lodging: $12K · Food and Beverage: $2,925 · Education: $34.63.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $88,878.60 |
| Travel and Lodging | $11,998.39 |
| Food and Beverage | $2,924.90 |
| Education | $34.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $252,374.93 | 2019-2025 | Axsos, Augment Injectable, Pro-Dense |
| Synthes USA Products LLC | $4,029.62 | 2019 | |
| Si-Bone, INC. | $2,427.01 | 2024 | |
| Gotham Surgical Solutions & Devices, INC. | $1,262.00 | 2019 | |
| Ossdsign USA Incorporated | $37.70 | 2024-2025 | Ossdsign Catalyst |
| Fidia Pharma USA INC. | $16.67 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philipp Leucht listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.